+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Quanterix Corp (QTRX) - Product Pipeline Analysis, 2021 Update

  • ID: 5367402
  • Company Profile
  • June 2021
  • 44 pages
  • GlobalData
  • Quanterix

FEATURED COMPANIES

  • Bio Techne Corp
  • Luminex Corp
  • Meso Scale Discovery
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform. It offers biomarker detection system, antibodies and elisa kits, bead-based immunoassay platform, and homebrew assays. Quanterix provides protein biomarker testing and custom assay development services. It markets diagnostics technology under the brands of Simoa, HD-X Analyzer, SR-X, SP-X Imaging and Analysis System, and Uman NF-Light. It's products finds application in detecting central nervous system (CNS), oncology, and cardiac biomarkers at ultra-low levels; measuring inflammatory markers in normal and disease samples, and cytokine levels and profiles in non-critical and critical COVID-19 patients. The company operates in the Netherlands, Sweden, Hong Kong, and China. Quanterix is headquartered in Billerica, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Quanterix Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio Techne Corp
  • Luminex Corp
  • Meso Scale Discovery
Quanterix Corp Company Overview
  • Quanterix Corp Company Snapshot
  • Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Quanterix Corp - Pipeline Analysis Overview
  • Quanterix Corp - Key Facts
  • Quanterix Corp - Major Products and Services
  • Quanterix Corp Pipeline Products by Development Stage
Quanterix Corp Pipeline Products Overview
  • AccuPSA Test
  • AccuPSA Test Product Overview
  • Antigen Detection Assay - Tuberculosis
  • Antigen Detection Assay - Tuberculosis Product Overview
  • Diagnostic Blood Test - Huntington’s Disease
  • Diagnostic Blood Test - Huntington’s Disease Product Overview
  • Digital ELISA - Crohn’s Disease
  • Digital ELISA - Crohn’s Disease Product Overview
  • Digital ELISA Assay - C. Difficile
  • Digital ELISA Assay - C. Difficile Product Overview
  • NeuroFilament Light Assay - Alzheimer’s Disease
  • NeuroFilament Light Assay - Alzheimer’s Disease Product Overview
  • POC Device - Neurological Injuries
  • POC Device - Neurological Injuries Product Overview
  • Simoa 3.0
  • Simoa 3.0 Product Overview
  • Simoa 4.0
  • Simoa 4.0 Product Overview
  • Simoa 5.0
  • Simoa 5.0 Product Overview
  • Simoa Antibody Test - COVID-19
  • Simoa Antibody Test - COVID-19 Product Overview
  • SiMoA HD-1 Analyzer - Botulinum Toxin Assay
  • SiMoA HD-1 Analyzer - Botulinum Toxin Assay Product Overview
  • Simoa HD-1 Analyzer - Lung Cancer
  • Simoa HD-1 Analyzer - Lung Cancer Product Overview
  • Simoa HD-1 Analyzer - Pancreatic Cancer
  • Simoa HD-1 Analyzer - Pancreatic Cancer Product Overview
  • SiMoA HD-1 Analyzer - Prostate Cancer Assay
  • SiMoA HD-1 Analyzer - Prostate Cancer Assay Product Overview
  • Simoa SARS-Cov-2 Antigen Test
  • Simoa SARS-Cov-2 Antigen Test Product Overview
  • sNfL Assay
  • sNfL Assay Product Overview
  • TAU-SIMOA ASSAY - ADRD
  • TAU-SIMOA ASSAY - ADRD Product Overview
  • TAU-SIMOA ASSAY - Alzheimer’s Disease
  • TAU-SIMOA ASSAY - Alzheimer’s Disease Product Overview
Quanterix Corp - Key Competitors

Quanterix Corp - Key Employees

Quanterix Corp - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Quanterix Corp, Recent Developments
  • Feb 23, 2021: Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
  • Feb 18, 2021: Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference
  • Feb 12, 2021: Quanterix announces Simoa joint laboratory with WuXi AppTec
  • Jul 29, 2020: Quanterix sNfL Assay and Simoa Technology first to measure neuronal injury in COVID-19 patients’ blood
  • Jul 20, 2020: Quanterix’ Simoa Technology powers new insights into COVID-19 immune response and reveals indicators of disease severity
  • May 26, 2020: HER2 and the future of breast cancer immunotherapy
  • May 13, 2020: Quanterix’ Simoa technology sets new standard in protein detection
  • May 01, 2020: Quanterix CEO and Powering Precision Health Founder Kevin Hrusovsky to appear on Passionate Pioneers Podcast
  • Apr 30, 2020: Svar offers a sensitive and specific cell-based iLite ADCC mVEGF assay
  • Jan 10, 2020: Quanterix to present at 38th Annual J.P. Morgan Healthcare Conference
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Quanterix Corp Pipeline Products by Equipment Type
  • Quanterix Corp Pipeline Products by Indication
  • Quanterix Corp, Key Facts
  • Quanterix Corp, Major Products and Services
  • Quanterix Corp Number of Pipeline Products by Development Stage
  • Quanterix Corp Pipeline Products Summary by Development Stage
  • AccuPSA Test - Product Status
  • AccuPSA Test - Product Description
  • Antigen Detection Assay - Tuberculosis - Product Status
  • Antigen Detection Assay - Tuberculosis - Product Description
  • Diagnostic Blood Test - Huntington’s Disease - Product Status
  • Diagnostic Blood Test - Huntington’s Disease - Product Description
  • Digital ELISA - Crohn’s Disease - Product Status
  • Digital ELISA - Crohn’s Disease - Product Description
  • Digital ELISA Assay - C. Difficile - Product Status
  • Digital ELISA Assay - C. Difficile - Product Description
  • NeuroFilament Light Assay - Alzheimer’s Disease - Product Status
  • NeuroFilament Light Assay - Alzheimer’s Disease - Product Description
  • POC Device - Neurological Injuries - Product Status
  • POC Device - Neurological Injuries - Product Description
  • Simoa 3.0 - Product Status
  • Simoa 3.0 - Product Description
  • Simoa 4.0 - Product Status
  • Simoa 4.0 - Product Description
  • Simoa 5.0 - Product Status
  • Simoa 5.0 - Product Description
  • Simoa Antibody Test - COVID-19 - Product Status
  • Simoa Antibody Test - COVID-19 - Product Description
  • SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status
  • SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description
  • Simoa HD-1 Analyzer - Lung Cancer - Product Status
  • Simoa HD-1 Analyzer - Lung Cancer - Product Description
  • Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status
  • Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description
  • SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status
  • SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description
  • Simoa SARS-Cov-2 Antigen Test - Product Status
  • Simoa SARS-Cov-2 Antigen Test - Product Description
  • sNfL Assay - Product Status
  • sNfL Assay - Product Description
  • TAU-SIMOA ASSAY - ADRD - Product Status
  • TAU-SIMOA ASSAY - ADRD - Product Description
  • TAU-SIMOA ASSAY - Alzheimer’s Disease - Product Status
  • TAU-SIMOA ASSAY - Alzheimer’s Disease - Product Description
Quanterix Corp, Key Employees
  • Quanterix Corp, Subsidiaries
  • Glossary
List of Figures
  • Quanterix Corp Pipeline Products by Equipment Type
  • Quanterix Corp Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • Bio Techne Corp
  • Ortho-Clinical Diagnostics Inc
  • NanoString Technologies Inc
  • Luminex Corp
  • Meso Scale Discovery
Note: Product cover images may vary from those shown
Adroll
adroll